Cai et al. developed and validated a non-invasive diagnostic model based on Genome-wide mapping of 5-hydroxymethylcytosines in cfDNA achieving an AUC of 0.85 in distinguish early HCC from chronic liver disease (CLD), thus outperforming AFP (AUC = 0.69) [77]. This evidence concerns the gene AFP and hepatocellular carcinoma.